Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- CheckyesterdayChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed; no substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed drug information for Pembrolizumab, Paclitaxel, and Carboplatin, while removing various terms related to esophageal cancer and other neoplasms.SummaryDifference4%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed. This indicates a transition to a newer version while eliminating previous notifications about service interruptions.SummaryDifference0.9%
Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.